Ultragreen Ai Ltd (SGX:ULG) Share Price

Company Profile

Business description
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
Contact
463 MacPherson Road
M463
Singapore368181
SGP
T: +65 98172903
https://www.ultragreen.ai
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
101

Recommended

International expansion is a distraction from valuable local business.

Roy Van Keulen | 14 May 2026

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.

Jacob Robbins | 14 May 2026

How the most traded shares in April stack up against our analysts views.

Tyger Fitzpatrick | 14 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,873.50	43.80	-0.49%
CAC 40	8,082.27	0.00	0.00%
DAX 40	24,456.26	319.45	1.32%
Dow JONES (US)	50,063.46	370.26	0.75%
FTSE 100	10,372.93	47.58	0.46%
HKSE	26,124.13	264.91	-1.00%
NASDAQ	26,635.22	232.88	0.88%
Nikkei 225	61,849.81	804.24	-1.28%
NZX 50 Index	12,918.04	107.03	-0.82%
S&P 500	7,501.24	56.99	0.77%
S&P/ASX 200	8,631.50	42.00	-0.48%
SSE Composite Index	4,165.55	12.37	-0.30%